WU-CART-007
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for WU-CART-007, covering 2024-11-20 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex) [Phase 2]